Ocular Therapeutix, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for OCUL, updated each market day.
OCUL AI Sentiment
AI sees no strong directional signal for Ocular Therapeutix, Inc. stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Sector
Exchange
Market Cap
$2,226,904,901
Cap Tier
Employees
325
Headquarters
BEDFORD, MA
Listed Since
July 25, 2014
Website
OCUL Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
OCUL Volatility
Ocular Therapeutix, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
